Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 473

Similar articles for PubMed (Select 9652763)

1.
2.

Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.

Dingemans AC, van Ark-Otte J, Span S, Scagliotti GV, van der Valk P, Postmus PE, Giaccone G.

Lung Cancer. 2001 May;32(2):117-28.

PMID:
11325482
3.
4.

Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.

Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE, Giaccone G.

Clin Cancer Res. 1999 Aug;5(8):2048-58.

5.

Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.

Eijdems EW, Zaman GJ, de Haas M, Versantvoort CH, Flens MJ, Scheper RJ, Kamst E, Borst P, Baas F.

Br J Cancer. 1995 Aug;72(2):298-306.

6.

Comparison of DNA topoisomerase II alpha expression in small cell and nonsmall cell carcinoma of the lung. In search of a mechanism of chemotherapeutic response.

Guinee DG Jr, Holden JA, Benfield JR, Woodward ML, Przygodzki RM, Fishback NF, Koss MN, Travis WD.

Cancer. 1996 Aug 15;78(4):729-35.

PMID:
8756364
7.

Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells.

Matsumoto Y, Takano H, Kunishio K, Nagao S, Fojo T.

Jpn J Cancer Res. 2001 Jul;92(7):778-84.

PMID:
11473729
8.

Expressions of topoisomerase IIα and BCRP in metastatic cells are associated with overall survival in small cell lung cancer patients.

Rijavec M, Silar M, Triller N, Kern I, Cegovnik U, Košnik M, Korošec P.

Pathol Oncol Res. 2011 Sep;17(3):691-6. doi: 10.1007/s12253-011-9370-2. Epub 2011 Apr 1.

PMID:
21455636
9.

[The expression of MRP, GST-pi, Topo IIalpha and COX-2 in epithelial ovarian cancer and its relationship to drug resistance and prognosis].

Cao DY, Shen K, Yang JX, Guan J.

Zhonghua Yi Xue Za Zhi. 2007 Jul 3;87(25):1738-41. Chinese.

PMID:
17919376
10.

Differential expression of DNA topoisomerase II alpha and -beta in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4.

Withoff S, de Vries EG, Keith WN, Nienhuis EF, van der Graaf WT, Uges DR, Mulder NH.

Br J Cancer. 1996 Dec;74(12):1869-76.

11.
12.

Differential expression of DNA topoisomerase II alpha and II beta genes between small cell and non-small cell lung cancer.

Syahruddin E, Oguri T, Takahashi T, Isobe T, Fujiwara Y, Yamakido M.

Jpn J Cancer Res. 1998 Aug;89(8):855-61.

PMID:
9765623
13.

[Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].

Yu DQ, Yi YF.

Ai Zheng. 2003 May;22(5):496-9. Chinese.

PMID:
12753710
16.

Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues.

Dingemans AM, van Ark-Otte J, van der Valk P, Apolinario RM, Scheper RJ, Postmus PE, Giaccone G.

Ann Oncol. 1996 Aug;7(6):625-30.

17.

Expression of drug resistance-related genes in head and neck squamous cell carcinomas and normal mucosa.

Hirata S, Katoh O, Oguri T, Watanabe H, Yajin K.

Jpn J Cancer Res. 2000 Jan;91(1):84-90.

PMID:
10744048
18.

Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines.

Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda T, Saijo N.

J Natl Cancer Inst. 1992 Jan 15;84(2):113-8.

PMID:
1310509
19.
20.

Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.

Zhou Z, Zwelling LA, Kawakami Y, An T, Kobayashi K, Herzog C, Kleinerman ES.

Cancer Res. 1999 Sep 15;59(18):4618-24.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk